• About
    • Adcendo
    • Leadership team
    • Board of Directors
  • Pipeline
    • Pipeline
    • Key publications
  • Patients
    • For Patients
    • Expanded Access Policy
  • Investors
    • Press releases and Media
    • Our investors
  • Careers & Values
  • Contact

Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells (2002)

Apr 26, 2002

Recent Posts

  • Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01
  • Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting
  • Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team
  • Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02
  • Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline

Recent Comments

No comments to show.

Contact Us

Adcendo ApS
For all inquiries, please contact adcendo
via the e-mail address info@adcendo.com

Connect now  

Cookie Policy
Privacy Policy
Job Applicant Privacy Notice
© Adcendo ApS, All rights reserved 2025

Connect now